Physician profile
Michael Stephen Nickoli
NPI 1831452580
$14,153.42
in general payments reported to CMS, 2019-2025
13 companies · $1,726 in 2025
The $1,726 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,693 · 2020: $66.72 · 2021: $695 · 2022: $2,727 · 2023: $1,923 · 2024: $4,322 · 2025: $1,726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,431 · Travel and Lodging: $3,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,430.74 |
| Travel and Lodging | $3,540.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,709.56 | 2019-2025 | Mako, Iconix, Aequalis Ascend Flex |
| Arthrex, INC. | $3,426.07 | 2022-2025 | |
| Cdc Medical LLC | $2,880.05 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $1,049.49 | 2019-2024 | Rosa, Persona, Mymobility Platform |
| Depuy Synthes Sales INC. | $642.24 | 2022-2025 | Na, Hammerlock, Va-Lcp |
| Djo, LLC | $429.35 | 2022-2025 | Aircast, Donjoy, Procare |
| Cosa Medical, LLC | $338.85 | 2024-2025 | |
| Medtronic, INC. | $266.95 | 2024-2025 | Plasmablade(Tm) |
| Miach Orthopaedics, INC. | $228.60 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $112.90 | 2022 | |
| Vericel Corporation | $34.41 | 2019-2021 | |
| Steris Corporation | $18.10 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $16.85 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nickoli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.